Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business... Show more
Sasol Limited (SSL) currently does not pay a dividend. The trailing twelve-month dividend stands at $0.00 per share, resulting in a 0.00% yield. Historically, the company distributed dividends semiannually, with the last payment of $0.0829 occurring on March 29, 2024. Under its updated policy, dividends are linked to free cash flow generation and require net debt to remain sustainably below $3 billion (excluding leases). This positions SSL as a company without an active dividend profile at present, rather than a high-yield or consistent dividend growth stock.
Sasol Limited (SSL) maintained semiannual dividend payments for many years, with amounts varying based on earnings and cash flow. Payouts included $0.5248 in September 2023 and $0.3842 in March 2023. However, the company significantly reduced or suspended distributions in 2024 amid elevated debt levels and macroeconomic pressures. No growth streak is active, and the focus has shifted from regular increases to balance sheet strengthening. The board has signaled potential resumption once financial targets are achieved.
With no current dividend, the payout ratio is 0.00%. Sustainability is governed by the revised policy requiring sustainable net debt below $3 billion (excluding leases). Recent free cash flow improvements and cost discipline support progress toward this threshold, expected between fiscal 2027 and 2028. Earnings coverage and overall financial stability are monitored closely, with the company prioritizing debt reduction over immediate distributions to ensure long-term viability.
Within the chemicals and energy sector, many peers maintain active dividend programs with yields ranging from 2% to 5% for established payers. Sasol Limited (SSL)’s current 0.00% yield stands below these averages due to its suspension. Once reinstated, the company’s profile could align more closely with peers focused on cyclical industries, though its debt-linked policy adds a layer of conditionality not present in all competitors.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your investment research.
Sasol Limited (SSL) currently offers no dividend income, making it unsuitable for investors seeking immediate yield. It may appeal to patient, long-term dividend growth investors who prioritize companies rebuilding financial flexibility through debt reduction and free cash flow improvement. The revised policy ties future payouts to a clear net debt target, providing a structured path to potential reinstatement. Conservative income investors may prefer to wait for resumption confirmation, while those focused on total return could monitor operational progress. All investors should evaluate the cyclical nature of the chemicals sector alongside balance sheet metrics before considering allocation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and Limitationsa manufacturer of industrial chemicals
Industry ChemicalsSpecialty